Literature DB >> 25049055

Navigated transcranial magnetic stimulation in amyotrophic lateral sclerosis.

Alexander V Chervyakov1, Ilya S Bakulin, Natalia G Savitskaya, Ivan V Arkhipov, Andrey V Gavrilov, Maria N Zakharova, Michael A Piradov.   

Abstract

INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a set of disorders associated with preferential degeneration of both upper and lower motor neurons. Navigated transcranial magnetic stimulation (nTMS) is a tool used to perform noninvasive functional brain mapping. We aimed to assess function of upper motor neurons in ALS.
METHODS: nTMS was performed on 30 patients with ALS (mean age 54.4 ± 12.1 years) and 24 healthy volunteers (mean age 32.7 ± 13.3 years).
RESULTS: The resting motor threshold (MT) was significantly higher in ALS patients compared with controls (P < 0.001). The mean map areas were smaller in patients with ALS than in healthy individuals, although some patients with short disease duration had extended maps.
CONCLUSIONS: Motor area maps serve as markers of upper motor neuron damage in ALS. Further research may elucidate the pathogenic mechanisms of the neurodegenerative process and aid in development of diagnostic and prognostic markers.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ALS; TMS; brain mapping; navigated transcranial magnetic stimulation; neurodegeneration

Mesh:

Year:  2014        PMID: 25049055     DOI: 10.1002/mus.24345

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Motor neuron disease: Evaluation of ALS via transcranial magnetic stimulation.

Authors:  Alex Chase
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

Review 2.  Transcranial Magnetic Stimulation as Treatment in Multiple Neurologic Conditions.

Authors:  Antonio H Iglesias
Journal:  Curr Neurol Neurosci Rep       Date:  2020-02-04       Impact factor: 5.081

Review 3.  Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.

Authors:  Christina N Fournier
Journal:  Neurotherapeutics       Date:  2022-07-11       Impact factor: 6.088

4.  Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial.

Authors:  Michael D Weiss; Eric A Macklin; Courtney E McIlduff; Steve Vucic; Brian J Wainger; Matthew C Kiernan; Stephen A Goutman; Namita A Goyal; Seward B Rutkove; Shafeeq S Ladha; I-Hweii Amy Chen; Matthew B Harms; Thomas H Brannagan; David Lacomis; Sasha Zivkovic; Maxwell Ma; Leo H Wang; Zachary Simmons; Michael H Rivner; Jeremy M Shefner; Merit E Cudkowicz; Nazem Atassi
Journal:  Muscle Nerve       Date:  2020-12-31       Impact factor: 3.217

Review 5.  Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

Authors:  Tonisha Kearney-Ramos; Margaret Haney
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-03-04       Impact factor: 5.201

6.  TMSmap - Software for Quantitative Analysis of TMS Mapping Results.

Authors:  Pavel A Novikov; Maria A Nazarova; Vadim V Nikulin
Journal:  Front Hum Neurosci       Date:  2018-07-09       Impact factor: 3.169

7.  Mapping of multiple muscles with transcranial magnetic stimulation: absolute and relative test-retest reliability.

Authors:  Maria Nazarova; Pavel Novikov; Ekaterina Ivanina; Ksenia Kozlova; Larisa Dobrynina; Vadim V Nikulin
Journal:  Hum Brain Mapp       Date:  2021-03-08       Impact factor: 5.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.